Bioactive lysophospholipids and their G protein-coupled receptors

Experimental Cell Research

Volumn 253, Issue 1, 1999, Pages 230-238

  Moolenaar, Wouter H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; RHO FACTOR; SPHINGOSINE 1 PHOSPHATE;

ASTROCYTE; ATHEROSCLEROSIS; CELL INVASION; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CYTOSKELETON; MITOGENESIS; NERVE FIBER GROWTH; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0033604620     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4702     Document Type: Article

References (86)

1. Moolenaar W. H. Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270:1995;12949-12952.
2. Moolenaar W. H., Kranenburg O., Postma F. R., Zondag G. C. M. Lysophosphatidic acid: G protein signaling and cellular responses. Curr. Opin. Cell Biol. 9:1997;168-173.
3. Chun J., Contos J. J., Munroe D. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs). Cell Biochem. Biophys. 30:1999;213-242.
4. Goetzl E. J., An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12:1998;1589-1598.
5. Spiegel S. Sphingosine 1-phosphate: A prototype of a new class of second messengers. J. Leukocyte Biol. 65:1999;341-344.
6. Hla T., Lee M. J., Ancellin N., Liu C. H., Thangada S., Thompson B. D., Kluk M. Sphingosine-1-phosphate: Extracellular mediator or intracellular second messenger. Biochem. Pharmacol. 58:1999;201-217.
7. Eichholtz T., Jalink K., Fahrenfort I., Moolenaar W. H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291:1993;677-680.
8. Yatomi Y., Ruan F. Q., Hakomori S. I., Igarashi Y. Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood. 86:1995;193-202.
9. Tigyi G., Miledi R. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromacytoma cells. J. Biol. Chem. 267:1992;21360-21367.
10. Igarashi Y., Yatomi Y. Sphingosine 1-phosphate is a blood constituent released from activated platelets, possibly playing a variety of physiological and pathophysiological roles. Acta Biochim. Pol. 45:1998;299-309.
11. Valet P., Pages C., Jeanneton O., Daviaud D., Barbe P., Record M., Saulnier-Blache J. S., Lafontan M. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J. Clin. Invest. 101:1998;1431-1438.
12. Fukami K., Takenawa T. Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal. J. Biol. Chem. 267:1992;10988-10993.
13. Olivera A., Spiegel S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature. 365:1993;557-560.
14. Van Brocklyn J. R., Lee M. J., Menzeleev R., Olivera A., Edsall L., Cuvillier O., Thomas D. M., Coopman P. J., Thangada S., Liu C. H., Hla T., Spiegel S. Dual actions of sphingosine-1-phosphate: Extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell Biol. 142:1998;229-240.
15. 2+ signaling by G-protein-coupled receptors. EMBO J. 17:1998;2830-2837.
16. Alemany R., Meyer zu Heringdorf D., van Koppen C. J., Jakobs K. H. Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase. J. Biol. Chem. 274:1999;3994-3999.
17. Einspahr K. J., Maeda M., Thompson G. A. Concurrent changes in Dunaliella salina ultrastructure and membrane phospholipid metabolism after hyperosmotic shock. J. Cell Biol. 107:1988;529-538.
18. Fourcade O., Simon M. F., Viode C., Rugani N., Leballe F., Ragab A., Fournie B., Sarda L., Chap H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 80:1995;919-927.
19. 2+ signaling pathways. Curr. Biol. 8:1998;386-392.
20. Xu Y., Gaudette D. C., Boynton J. D., Frankel A., Fang X. J., Sharma A., Hurteau J., Casey G., Goodbody A., Mellors A. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res. 1:1995;1223-1232.
21. Westermann A. M., Havik E., Postma F. R., Beijnen J. H., Dalesio O., Moolenaar W. H., Rodenhuis S. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann. Oncol. 9:1998;437-442.
22. Xu Y., Shen Z., Wiper D. W., Wu M., Morton R. E., Elson P., Kennedy A. W., Belinson J., Markman M., Casey G. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA. 280:1998;719-723.
23. Siess W., Zangl K. J., Essler M., Bauer M., Brandl R., Corrinth C., Bittman R., Tigyi G., Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 96:1999;6931-6936.
24. van der Bend R. L., Brunner J., Jalink K., van Corven E. J., Moolenaar W. H., van Blitterswijk W. J. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J. 11:1992;2495-2501.
25. Hecht J. H., Weiner J. A., Post S. R., Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135:1996;1071-1083.
26. Jalink K., Eichholtz T., Postma F. R., Van Corven E. J., Moolenaar W. H. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: Similarity to thrombin action. Cell Growth Differ. 4:1993;247-255.
27. Jalink K., Van Corven E. J., Hengeveld T., Morii N., Narumiya S., Moolenaar W. H. Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein rho. J. Cell Biol. 126:1994;801-810.
28. Weiner J. A., Hecht J. H., Chun J. Lysophosphatidic acid receptor gene vzg-1/lpA1/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. J. Comp. Neurol. 7:1998;587-598.
29. Allard J., Barron S., Diaz J., Lubetzki C., Zalc B., Schwartz J. C., Sokoloff P. A rat G protein-coupled receptor selectively expressed in myelin-forming cells. Eur. J. Neurosci. 10:1998;1045-1053.
30. Lee M. J., Van B. J., Thangada S., Liu C. H., Hand A. R., Menzeleev R., Spiegel S., Hla T. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science. 279:1998;1552-1555.
31. Zondag G. C., Postma F. R., Etten I. V., Verlaan I., Moolenaar W. H. Sphingosine 1-phosphate signaling through the G-protein-coupled receptor Edg-1. Biochem. J. 330:1998;605-609.
32. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J. Biol. Chem. 273:1998;27104-27110.
33. Lee M. J., Thangada S., Liu C. H., Thompson B. D., Hla T. Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist. J. Biol. Chem. 273:1998;22105-22112.
34. Zhang G., Contos J. J., Weiner J. A., Fukushima N., Chun J. Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. Gene. 227:1999;89-99.
35. Okamoto H., Takuwa N., Yatomi Y., Gonda K., Shigematsu H., Takuwa Y. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16. Biochem. Biophys. Res. Commun. 260:1999;203-208.
36. An S., Bleu T., Hallmark O. G., Goetzl E. J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273:1998;7906-7910.
37. Ancellin N., Hla T. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J. Biol. Chem. 274:1999;18997-19002.
38. Bandoh K., Aoki J., Hosono H., Kobayashi S., Kobayashi T., Murakami-Murofushi K., Tsujimoto M., Arai H., Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274:1999;27776-27785.
39. Fukushima N., Kimura Y., Chun J. A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl. Acad. Sci. USA. 95:1998;6151-6156.
40. An S., Bleu T., Zheng Y., Goetzl E. J. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. Mol. Pharmacol. 54:1998;881-888.
41. Kon J., Sato K., Watanabe T., Tomura H., Kuwabara A., Kimura T., Tamama K., Ishizuka T., Murata N., Kanda T., Kobayashi I., Ohta H., Ui M., Okajima F. J. Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells. J. Biol. Chem. 274:1999;23940-23947.
42. Windh R. T., Lee M. J., Hla T., An S., Barr A. J., Manning D. R. Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J. Biol. Chem. 274:1999;27351-27358.
43. Liu C. H., Thangada S., Lee M. J., Van Brocklyn J. R., Spiegel S., Hla T. Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol. Biol. Cell. 10:1999;11779-11790.
44. Alblas J., van Etten I., Khanum A., Moolenaar W. H. C-terminal truncation of the neurokinin-2 receptor causes enhanced and sustained agonist-induced signaling. J. Biol. Chem. 270:1995;8944-8951.
45. Alblas J., van Etten I., Moolenaar W. H. Truncated, desensitization-defective neurokinin receptors mediate sustained MAP kinase activation, cell growth and transformation by a Ras-independent mechanism. EMBO J. 15:1996;3351-3360.
46. 2+-mobilizing stimulus for fibroblasts. J. Biol. Chem. 265:1990;12232-12239.
47. Epstein R. J., Druker B. J., Irminger J. C., Jones S. D., Roberts T. M., Stiles C. D. Extracellular calcium mimics the actions of platelet-derived growth factor on mouse fibroblasts. Cell Growth Differ. 3:1992;157-164.
48. Piazza G. A., Ritter J. L., Baracka C. A. Lysophosphatidic acid induction of transforming growth factors alpha and beta: Modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp. Cell Res. 216:1995;51-64.
49. Weiner J. A., Chun J. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc. Natl. Acad. Sci. USA. 96:1999;5233-5238.
50. Allard J., Barron S., Trottier S., Cervera P., Daumas-Duport C., Leguern E., Brice A., Schwartz J. C., Sokoloff P. Edg-2 in myelin-forming cells: Isoforms, genomic mapping, and exclusion in Charcot-Marie-Tooth disease. Glia. 26:1999;176-185.
51. Koh J. S., Lieberthal W., Heydrick S., Levine J. S. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway. J. Clin. Invest. 102:1998;716-727.
52. Levine J. S., Koh J. S., Triaca V., Lieberthal W. Lysophosphatidic acid: A novel growth and survival factor for renal proximal tubular cells. Am. J. Physiol. 273:1997;F575-F585.
53. Goetzl E. J., Kong Y., Mei B. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J. Immunol. 162:1999;2049-2056.
54. Hisano N., Yatomi Y., Satoh K. Induction and suppression of endothelial cell apoptosis by sphingolipids: A possible in vitro model for cell-cell interactions between platelets and endothelial cells. Blood. 93:1999;4293-4299.
55. Postma F. R., Jalink K., Hengeveld T., Moolenaar W. H. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: Action through a specific cell surface receptor. EMBO J. 15:1996;2388-2392.
56. Saito S. Effects of lysophosphatidic acid on primary cultured chick neurons. Neurosci. Lett. 229:1997;73-76.
57. Postma F. R., Jalink K., Hengeveld T., Bot A. G., Alblas J., de Jonge H. R., Moolenaar W. H. Serum-induced membrane depolarization in quiescent fibroblasts: Activation of a chloride conductance through the G protein-coupled LPA receptor. EMBO J. 15:1996;63-72.
58. Dubin A. E., Bahnson T., Weiner J. A., Fukushima N., Chun J. Lysophosphatidic acid stimulates neurotransmitter-like conductance changes that precede GABA and L-glutamate in early, presumptive cortical neuroblasts. J. Neurosci. 19:1999;1371-1381.
59. Kozma R., Sarner S., Ahmed S., Lim L. Rho family GTPases and neuronal growth cone remodelling: Relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid. Mol. Cell. Biol. 17:1997;1201-1211.
60. Hirose M., Ishizaki T., Watanabe N., Uehata M., Kranenburg O., Moolenaar W. H., Matsumura F., Maekawa M., Bito H., Narumiya S. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J. Cell Biol. 141:1998;1625-1636.
61. Kranenburg O., Poland M., van Horck F. P., Drechsel D., Hall A., Moolenaar W. H. Activation of RhoA by lysophosphatidic acid and Gα12/13 subunits in neuronal cells: Induction of neurite retraction. Mol. Biol. Cell. 10:1999;1851-1857.
62. Gohla A., Harhammer R., Schultz G. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho. J. Biol. Chem. 273:1998;4653-4659.
63. Kozasa T., Jiang X., Hart M. J., Sternweis P. M., Singer W. D., Gilman A. G., Bollag G., Sternweis P. C. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science. 280:1998;2109-2111.
64. Tigyi G., Hong L., Yakubu M., Parfenova H., Shibat M., Leffler C. W. Lysophosphatidic acid alters cerebrovascular reactivity in piglets. Am. J. Physiol. 268:1995;H2048-H2055.
65. Thomson F. J., Clark M. A. Purification of a phosphatidic-acid-hydrolysing phospholipase A2 from rat brain. Biochem. J. 306:1995;305-309.
66. Manning T. J., Sontheimer H. Bovine serum albumin and lysophosphatidic acid stimulate calcium mobilization and reversal of cAMP-induced stellation in rat spinal cord astrocytes. Glia. 20:1997;163-172.
67. Suidan H. S., Nobes C. D., Hall A., Monard D. Astrocyte spreading in response to thrombin and lysophosphatidic acid is dependent on the Rho GTPase. Glia. 21:1997;244-252.
68. Ramakers G. A., Moolenaar W. H. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid. Exp. Cell Res. 245:1998;252-262.
69. Manning T. J., Rosenfeld S. S., Sontheimer H. Lysophosphatidic acid stimulates actomyosin contraction in astrocytes. J. Neurosci. Res. 53:1998;343-352.
70. Ridet J. L., Malhotra S. K., Privat A., Gage F. H. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci. 20:1997;570-577.
71. Grabham P., Cunningham D. D. Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: Involvement of tyrosine phosphorylation. J. Neurochem. 64:1995;583-591.
72. 2+ signal and shape changes in C6 rat glioma cells. J. Neurosci. Res. 52:1998;427-434.
73. Imamura F., Horai T., Mukai M., Shinkai K., Sawada M., Akedo H. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun. 193:1993;497-503.
74. Yoshioka K., Matsumura F., Akedo H., Itoh K. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J. Biol. Chem. 273:1998;5146-5154.
75. Imamura F., Mukai M., Ayaki M., Takemura K., Horai T., Shinkai K., Nakamura H., Akedo H. Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells. Clin. Exp. Metastasis. 17:1999;141-148.
76. Lummen G., Virchow S., Rumenapp U., Schmidt M., Wieland T., Otto T., Rubben H., Jakobs K. H. Identification of G protein-coupled receptors potently stimulating migration of human transitional-cell carcinoma cells. Naunyn Schmiedeberg's Arch. Pharmacol. 356:1997;769-776.
77. O'Connor K. L., Shaw L. M., Mercurio A. M. Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells. J. Cell Biol. 143:1998;1749-1760.
78. Stam J. C., Michiels F., van der Kammen R. A., Moolenaar W. H., Collard J. G. Invasion of T-lymphoma cells: Cooperation between Rho family GTPases and lysophospholipid receptor signaling. EMBO J. 17:1998;4066-4074.
79. Sadahira Y., Ruan F., Hakomori S., Igarashi Y. Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Proc. Natl. Acad. Sci. USA. 89:1992;9686-9690.
80. Yamamura S., Sadahira Y., Ruan F., Hakomori S., Igarashi Y. Sphingosine-1-phosphate inhibits actin nucleation and pseudopodium formation to control cell motility of mouse melanoma cells. FEBS Lett. 382:1996;193-197.
81. Yamamura S., Yatomi Y., Ruan F., Sweeney E. A., Hakomori S., Igarashi Y. Sphingosine 1-phosphate regulates melanoma cell motility through a receptor-coupled extracellular action and in a pertussis toxin-insensitive manner. Biochemistry. 36:1997;10751-10759.
82. Wang F., Nohara K., Olivera A., Thompson E. W., Spiegel S. Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate. Exp. Cell Res. 247:1999;17-28.
83. Kawa S., Kimura S., Hakomori S., Igarashi Y. Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate. FEBS Lett. 420:1997;196-200.
84. Guo Z., Liliom K., Fischer D. J., Bathurst I. C., Tomei L. D., Kiefer M. C., Tigyi G. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. Proc. Natl. Acad. Sci. USA. 93:1996;14367-14372.
85. Zhang Q., Peyruchaud O., French K. J., Magnusson M. K., Mosher D. F. Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rho-dependent signal pathway. Blood. 93:1999;2984-2990.
86. Zhang Q., Magnusson M. K., Mosher D. F. Lysophosphatidic acid and microtubule-destabilizing agents stimulate fibronectin matrix assembly through Rho-dependent actin stress fiber formation and cell contraction. Mol. Biol. Cell. 8:1997;1415-1425.